99 results on '"Goéré, D"'
Search Results
2. Centalized oncologic surgery: Yes? No? Why? Where do we stand?
3. Trattamento chirurgico curativo delle carcinosi peritoneali
4. Tratamiento quirúrgico de la carcinomatosis peritoneal con fines curativos
5. Traitement prophylactique des métastases péritonéales colorectales
6. Introduction
7. Conclusion
8. Infection nosocomiale à SARS-Cov-2 dans les services de chirurgie digestive
9. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery
10. Accord d’experts français pour la prise en charge des métastases péritonéales de cancers colo-rectaux
11. Management of colorectal peritoneal metastases: Expert opinion
12. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial
13. A UNICANCER phase III trial of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. PRODIGE 7.
14. REsect: Blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization
15. REsect: blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization
16. Results of curative strategy in patients with peritoneal and extraperitoneal metastases from colorectal cancer
17. Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer
18. Is R1 hepatecomy still relevant in the contemporary management of colorectal liver metastases? long-term outcomes from a multi-institutional Bi-national analysis
19. Chirurgie des carcinoses péritonéales colorectales : quelles limites ?
20. Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE)
21. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin
22. Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study
23. Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC
24. Eviscerazione pelvica per cancro
25. Exenteración pélvica por cáncer
26. Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei
27. Place de la chirurgie de cytoréduction maximaliste chez les patients atteints d’un pseudomyxome péritonéal non résécable
28. 98. Perioperative outcomes of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal carcinomatosis: PRODIGE 7 randomized trial
29. Interféron alpha pour le traitement des patients atteints de phéochromocytome/paragangliome métastatique
30. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases
31. A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application
32. Single-port endoscopic mesocolic and mesorectal excision using an extraperitoneal approach
33. Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer
34. Carcinoses péritonéales d’origine inhabituelle : y a-t-il une place pour la chimiohyperthermie intrapéritonéale ?
35. Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery
36. Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?
37. Minimally invasive compared to open re-hepatectomy for colorectal liver metastases: A multi-institutional propensity-matched analysis of short and long-term outcomes
38. Colostomie périnéale pseudocontinente par cœlioscopie single port
39. Laparoscopic single port pseudo-continent perineal colostomy
40. Abdominal surgical emergencies in patients with advanced cancer
41. Urgences abdominales chirurgicales en situation oncologique avancée
42. Simple criteria to predict margin involvement after chemoradiotherapy and sphincter-sparing for low rectal cancer
43. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
44. Parenteral and enteral nutritional support (excluding immunonutrition)
45. Second-look surgery plus HIPEC for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Should we resect the initial anastomosis? An observational study
46. Therapeutic Strategies for Advanced Pancreatic Neuroendocrine Tumors with Segmental Portal Hypertension
47. Stratégie chirurgicale pour les cancers du bas rectum
48. Assistance nutritionnelle parentérale et entérale (hors immunonutrition)
49. Surgical strategy for low rectal cancers
50. Autologous peritoneo-fascial graft: A technique for vascular reconstruction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.